Article
Adeno-associated viral vectors for the treatment of hemophilia
27 Nov 2015
Abstract excerpt
Gene transfer studies for the treatment of hemophilia began more than two decades ago. A large body of pre-clinical work evaluated a variety of vectors and target tissues, but by the start of the new millennium it became evident that adeno-associated viral (AAV)-mediated gene transfer to the liver held great promise as a therapeutic tool. The transition to the clinical arena uncovered a number of unforeseen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
